During this challenging time of the COVID-19 pandemic, The health and safety of our patients and our staff is our highest priority at Hygieacare.
Following the guidance from public health authorities to limit the spread of COVID-19 for maintaining a safe environment, We have implemented multiple precautionary measures in the Hygieacare Centers.
We are grateful to the healthcare professionals on the front lines who are fighting to contain the virus and help patients with COVID-19.
In 2014 Gavriel D. Meron, founder and former CEO of Given Imaging – the Company that successfully brought the PillCam to the world – partnered with Texas-based Lifestream Purification Systems to form HyGIeaCare, Inc. to bring the HyGIeaCare FDA-cleared System, HygiPrep® and HygiRelief® procedures exclusively to the GI world.
The goal of HyGIeaCare is to provide unique services and solutions to gastroenterologists to deliver better GI outcomes for their patients and their practice through a chain of HyGIeaCare Centers to be established in the US and throughout the world.
In the US, 14.5M screening colonoscopies are performed each year, and this number is growing annually. According to the recently released US Multi-Society Task Force Consensus Statement on Adequate Bowel Cleansing for Colonoscopy, up to 20 – 25 percent of all colonoscopies are reported to have an inadequate bowel preparation. An incomplete standard prep makes it difficult to detect precancerous lesions. Current prep is also burdensome. There is clearly a need for a better way to prep colons.
Gavriel (Gabi) brings over 40 years of leadership experience to HyGIeaCare®, with 20 years of experience in the gastroenterology market. In 2014, Gabi founded Hygieacare Inc. and serves as its Chairman and CEO.
In 2006, Gabi established M.G.D. Management Services and Investments Ltd. In Israel, serving as its Chairman and CEO, mainly providing management services (Mauna Kea Technologies, Spirocor Inc., novoGI Ltd., GI View, Eltek Ltd. and Smart Medical Systems).
In 1998 Gabi founded Given Imaging Ltd. and served as President and CEO till 2006. Prior to that, Mr. Meron held executive positions, including: CEO of Applitec Ltd., 1996 – 1997; General Manager and COO of Optibase Ltd. (Nasdaq: OBAS),1994 – 1995; CFO of InterPharm Laboratories Ltd. (NASDAQ: IPLLF), 1988 – 1993; VP Finance and Administration of Numax Electronics Inc., Hauppauge, NY, 1985 – 1987; Head of Corporate Budgets for the Tadiran Group,1983 – 1985; Officer in the Israel Defense Forces General Headquarters, retired Major – 1973 – 1983. Gabi has an M.B.A. from the Recanati School of Business, Tel Aviv University (1979) and a B.A. in Economics and Statistics from the Hebrew University, Jerusalem (1973).
Liat joined Hygieacare Inc as CFO in 2015 and brings over 25 years’ experience in financial leadership roles.
Liat provided financial management and advisory services to various multinational companies and Venture Capital funds and served as Chief Financial Officer in the healthcare sector including Israel Healthcare Ventures, Spirocor Ltd., novoGI Inc .
In 1993 Liat established VSH, a CPA firm in Tel-Aviv.
Liat is a Certified Public Accountant by profession and holds both an MBA and BA in Economics and Accounting from the Tel-Aviv University in Israel.
Dawn brings over 20 years of management experience in the medical device industry, including 10 years in the field of gastroenterology. Prior to joining Hygieacare Dawn held management positions in multiple medical device start-up companies: Sonacare Medical, Inc.; Kalaco Scientific, Inc.; Given Imaging, Inc; and Novoste, Inc. Dawn led a team to receive the first de novo approval of a prostate cancer device while at Sonacare Medical, Inc. She has extensive experience managing clinical trials and regulatory submissions, as well as maintaining Quality Management Systems.
Dawn received her Bachelors of Science in Nursing at the University of Georgia Southern, and her Masters in Business Administration from Brenau University. She received her certification as a Clinical Research Associate.
Steve brings over 25 years of sales and leadership experience in the Medical Device market, including 12+ years in the GI space and 3 early-stage startups. Prior to joining Hygieacare Steve was Area Vice President for Olympus America, one of the largest Medical Device companies in the GI market. Prior to working for Olympus he was Area Sales Director at Exact Sciences where he helped build and lead the sales team which commercialized stool DNA testing for Colorectal cancer screening. Before Exact Sciences he was Area Vice President of Sales at Covidien’s, GI Solutions division, where he managed a team that helped bring to market a minimally invasive treatment to treat Barrett’s esophagus, a precursor to Esophageal Cancer.
Steve received his Bachelors of Science in Marketing and Management from LaSalle University in Phil PA.
Michal brings over 20 years of experience in marketing in the medical device industry. Michal is employed by M.G.D. Management Services & Investments Ltd. In Israel providing Marketing services to HyGIeaCare and has held senior positions in marketing at companies including novoGI Inc., Spirocor Ltd., Virtual Point Ltd., Dafna Wiseman & Lavi Ltd.
Michal studied at Bar-Ilan University, Ramat Gan, Israel, where she received an M.A. in Sociology, a B.A. in Social Sciences – Psychology and Sociology, and a Diploma in Organizational Consulting and Development.
Orly Levitan, PhD, joined Hygieacare in 2018 and brings 20 years of multidisciplinary and international research experience. At Hygieacare® Inc., Dr. Levitan is responsible for all the scientific and clinical data reporting and publications and the company’s IT and data-related pipelines. She is also directly managing all the company’s microbiome initiatives and research programs aimed at maximizing the value of the company’s products and services. Her responsibilities include initiating, forming, and maintaining collaborations, both with the private sector and the scientific-academic world. Dr. Levitan believes that the future of modern medicine is rooted in personalized and preventative microbiome-based practices.
Dr. Levitan received her BSc and MSc from Bar Ilan University (Ramat Gan, Israel) and conducted her PhD as part of a German-Israeli grant, graduating from Bar Ilan University. She then completed five years as a post-doctoral associate and became a research professor (2015-2018) at Rutgers University (NJ, USA). Dr. Levitan is now holding a visiting professor affiliation with Rutgers University (NJ, USA) and is an avid science communicator and educator.
Cheryl is an experienced professional with over 25 years of providing analytical and leadership skills. A key member of senior management teams with emphasis on strategic contributions in development, implementation, market planning, and launch of innovative healthcare products. Extensive experience in reimbursement assessment of new technology, recognized achievement in securing positive payer recognition, coverage and payment of medical device and healthcare services with Medicare (CMS), Third Party Commercial Payers, and Managed Care organizations. Accomplished acquisition of new CPT/HCPCS coding through the AMA (American Medical Association) for multiple medical products.
Prior to joining HyGieacare, Cheryl held key management positions with multiple medical companies; Medtronic, Ethicon, Johnson and Johnson, Eli Lily, Seno Medical and 11 plus years in GI with Given Imaging and served in a consultant role with 3M Pharmaceuticals, St Jude Medical, Mereteck, Cryolife, and FemRX.
Cheryl studied at the University of Minnesota, Oral Roberts University, College of Natural Health and holds Certificates in Chemical Dependency Technician, FeldenKrais ATM Practitioner, Level Two Reiki Healing, and Level One Lymphatic Therapeutic Therapy and has completed courses including; Women in Business, Quality Management, Executive Leadership Management.
During this challenging time of the COVID-19 pandemic, The health and safety of our patients and our staff is our highest priority at Hygieacare.
Following the guidance from public health authorities to limit the spread of COVID-19 for maintaining a safe environment, We have implemented multiple precautionary measures in the Hygieacare Centers.
We are grateful to the healthcare professionals on the front lines who are fighting to contain the virus and help patients with COVID-19.